Valeant Bond Price Pukes As Moody's Threatens Downgrade Over Weak Performance
With CDS markets implying around a 40% probability of default, Moody's has issued a warning over Valeant's deleveraging prospects (and ability to deliver sustainable growth) putting $31 billion of biotech debt on watch for downgrade. VRX bonds are down dramatically on the day.. not the forst day back at work Pearson was hoping for.